04.04.2024 -
Danish drugmaker Genmab has agreed to buy privately-owned US biotechnology company ProfoundBio for $1.8 billion. ProfoundBio develops novel ADCs and ADC technologies for...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)